Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Simulations Plus, Inc.NASDAQ: SLP

Net Income · Q2 FY2026 · quarter ended Feb 2026

Net income growth accelerates

Q2 FY2026 net income of $4.54M rose 47.5% year over year, ahead of the -964.8% change in trailing-twelve-month net income. Sequentially, it rose 570.9% from the prior quarter.

Context

  • Net income amounted to 81.7% of revenue in FY2025, up 67.5 pp from a year earlier.
  • Net income increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 3 analysts of $18.15M (+128.0%) for the fiscal year ending Aug 2026, a step up from the -750.2% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterFeb 2026
$4.54M+570.9% QoQ
Last fiscal yearAug 2025
-$64.72M-750.2% YoY
LTMFeb 2026
-$62.79M-964.8% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+47.5%+107.0%+59.4 pp
1 year-750.2%+128.0%+878.2 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(64.72M) USD
Year-over-year change
-750.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -964.8% is the lowest of 11, against a peer median of +26.8%.
  • Net income amounts to 78.0% of revenue for SLP, versus a peer median of 98.8%.
SLP Competitors
Net Income for SLP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AGLAgilon Health, Inc.LTM Mar 2026$354.54M USD+41.1%+54.1%6.1%
NAKANakamoto Inc.LTM Mar 2026$289.97M USD+6530.4%+173.9%7397.8%
DHDefinitive Healthcare Corp.LTM Mar 2026$182.83M USD-71.5%+107.7%76.7%
KRROKorro Bio, Inc.LTM Mar 2026$113.5M USD+29.8%+26.4%2954.1%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$80.17M USD+23.8%-3.4%98.8%
ANROAlto Neuroscience, Inc.LTM Mar 2026$74.31M USD+17.6%+31.7%—
ACIUAC Immune S.A.LTM Dec 2025CHF 70.34M CHF+38.1%-1.7%1968.6%
CLLSCellectis S.A.LTM Mar 2026$67.27M USD+11.1%-11.8%98.8%
SLPSimulations Plus, Inc.LTM Feb 2026$62.79M USD-964.8%—78.0%
NRCNational Research CorporationLTM Mar 2026$9.04M USD-62.7%-28.5%6.5%
OPRXOptimizeRx CorporationLTM Mar 2026$6.84M USD+144.4%—6.4%
Peer median (excluding SLP) —+26.8%+26.4%98.8%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Net Income9.78M12.48M9.96M9.95M(64.72M)
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
Deferred Income Tax(628K)(270K)(2.1M)(1.77M)(5.43M)
Stock-Based Compensation2.75M3.04M4.83M6.54M6.35M
Change in Working Capital974K(2.62M)5.1M(4.21M)(2.59M)
Accounts Receivables(2.43M)(3.94M)4.1M3.13M(581K)
Inventory3.15M0000
Accounts Payables39K(162K)(81K)(477K)(132K)
Other Working Capital210K1.48M1.09M(6.86M)(1.87M)
Other Non-Cash Items2.74M1.7M219K(2.86M)76.29M
Operating Cash Flow19.2M17.9M21.86M13.32M18.13M
Capital Expenditures(4.58M)(3.97M)(4.27M)(566K)(713K)
Acquisitions (Net)2.95M3.15M(8.22M)(98.77M)0
Purchases of Investments(122.4M)(100.85M)(95.05M)(67.16M)(6.5M)
Sales of Investments100.23M109.12M114.91M116.27M15.01M
Other Investing Activities(2.95M)(3.15M)(3.82M)(3.74M)(4.24M)
Investing Cash Flow(26.74M)4.31M7.37M(53.97M)3.56M
Debt Repayment00000
Common Stock Issued1.46M891K0731K430K
Common Stock Repurchased00(20M)00
Dividends Paid(4.81M)(4.85M)(4.81M)(4.8M)0
Other Financing Activities(1.33M)(3.67M)1.54M(2.5M)(1.58M)
Financing Cash Flow(4.68M)(7.62M)(23.27M)(6.57M)(1.15M)
Effect of Forex Changes00000
Net Change in Cash(12.22M)14.58M5.96M(47.21M)20.54M
Free Cash Flow14.63M13.93M17.58M12.75M17.41M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.